These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. Cha JY; Repa JJ J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947 [TBL] [Abstract][Full Text] [Related]
24. Effects of fish oil feeding and fasting on LXRalpha/RXRalpha binding to LXRE in the SREBP-1c promoter in mouse liver. Nakatani T; Katsumata A; Miura S; Kamei Y; Ezaki O Biochim Biophys Acta; 2005 Sep; 1736(1):77-86. PubMed ID: 16112614 [TBL] [Abstract][Full Text] [Related]
25. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of gomisin N against hepatic steatosis through AMPK activation. Yun YR; Kim JH; Kim JH; Jung MH Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Yap F; Craddock L; Yang J Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332 [TBL] [Abstract][Full Text] [Related]
28. ChREBP and LXRα mediate synergistically lipogenesis induced by glucose in porcine adipocytes. Zhang GH; Lu JX; Chen Y; Guo PH; Qiao ZL; Feng RF; Chen SE; Bai JL; Huo SD; Ma ZR Gene; 2015 Jul; 565(1):30-8. PubMed ID: 25827716 [TBL] [Abstract][Full Text] [Related]
29. Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway. Lee JH; Jung JY; Jang EJ; Jegal KH; Moon SY; Ku SK; Kang SH; Cho IJ; Park SJ; Lee JR; Zhao RJ; Kim SC; Kim YW Exp Biol Med (Maywood); 2015 Apr; 240(4):508-18. PubMed ID: 25125496 [TBL] [Abstract][Full Text] [Related]
31. Maternal resveratrol intake during lactation attenuates hepatic triglyceride and fatty acid synthesis in adult male rat offspring. Tanaka M; Kita T; Yamasaki S; Kawahara T; Ueno Y; Yamada M; Mukai Y; Sato S; Kurasaki M; Saito T Biochem Biophys Rep; 2017 Mar; 9():173-179. PubMed ID: 28956002 [TBL] [Abstract][Full Text] [Related]
32. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Seo MS; Kim JH; Kim HJ; Chang KC; Park SW Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164 [TBL] [Abstract][Full Text] [Related]
33. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism. Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440 [TBL] [Abstract][Full Text] [Related]
34. Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation. Han JY; Park SH; Yang JH; Kim MG; Cho SS; Yoon G; Cheon SH; Ki SH Toxicol Res; 2014 Mar; 30(1):19-25. PubMed ID: 24795795 [TBL] [Abstract][Full Text] [Related]
35. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis. Cui XB; Luan JN; Chen SY J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570 [TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis. Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856 [TBL] [Abstract][Full Text] [Related]
37. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Han CY; Ki SH; Kim YW; Noh K; Lee DY; Kang B; Ryu JH; Jeon R; Kim EH; Hwang SJ; Kim SG Antioxid Redox Signal; 2011 Jan; 14(2):187-202. PubMed ID: 20560786 [TBL] [Abstract][Full Text] [Related]
38. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα. Zhong D; Zhang Y; Zeng YJ; Gao M; Wu GZ; Hu CJ; Huang G; He FT Lipids Health Dis; 2013 Mar; 12():32. PubMed ID: 23496987 [TBL] [Abstract][Full Text] [Related]
40. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]